Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Activist Investor Elliott Pushes for Breakup of Barrick Gold

Felix Baarz by Felix Baarz
November 21, 2025
in Analysis, Commodities, Gold & Precious Metals, Mergers & Acquisitions
0
Barrick Stock
0
SHARES
75
VIEWS
Share on FacebookShare on Twitter

The mining sector’s tranquility has been shattered by activist investor Elliott Investment Management, which has built a substantial stake in Barrick Gold and is advocating for dramatic corporate changes. This development arrives at a paradoxical time for the company, which recently posted record operational results yet finds itself embroiled in strategic uncertainty. Investors are now grappling with a critical dilemma: will this activist pressure unlock significant value or plunge the mining behemoth into a protracted period of internal conflict?

Strong Operational Results Overshadowed by Strategic Turmoil

Barrick’s recent third-quarter performance would typically be a cause for celebration. The company reported robust figures, including an adjusted profit of $0.58 per share and a record-setting operational cash flow of $2.4 billion. However, these fundamental strengths are being almost entirely eclipsed by the strategic confrontation with Elliott. The market is currently dismissing the operational successes, choosing instead to focus on the risks associated with a potential corporate overhaul and confirmed leadership departures within the North American division.

The Elliott Proposal: A Radical Corporate Split

At the heart of the volatility is the specific plan put forward by the notorious hedge fund. Elliott Management, known for its aggressive and uncompromising campaigns, is pushing for a complete fragmentation of the mining giant. Market participants are already speculating on the likely structure of such a split, which would create two separate, publicly traded entities:

Should investors sell immediately? Or is it worth buying Barrick?

  • A North American-focused entity that would concentrate on stable, high-margin assets located in Nevada and the Dominican Republic.
  • An International entity that would bundle together the geopolitically more complex mining operations in regions like Africa and Asia, including projects in Mali and Pakistan.

The underlying rationale is straightforward: by cleaving off the riskier international portfolio, the inherent value of the safer North American assets could be fully realized and appreciated by the market. Nevertheless, the sheer scale of such a restructuring, combined with the executive-level instability, is generating significant near-term volatility for the stock.

External Market Pressures Compound Internal Struggles

Compounding the internal power struggle is a challenging macroeconomic backdrop for the gold sector. The price of the precious metal is currently testing key support levels and is under pressure from shifting interest rate expectations. When gold weakens, even highly efficient producers like Barrick face headwinds, as investors often shift to a “risk-off” mentality ahead of the weekend.

Despite the ongoing turbulence, Barrick’s shares, trading at approximately €31.42, remain within striking distance of the 52-week high set just two days ago. The central question for investors is whether the potential value creation from a breakup outweighs the fears of a drawn-out and disruptive battle with a determined activist fund. Until this question is resolved, the stock is likely to remain highly sensitive to news flow.

Ad

Barrick Stock: Buy or Sell?! New Barrick Analysis from February 8 delivers the answer:

The latest Barrick figures speak for themselves: Urgent action needed for Barrick investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 8.

Barrick: Buy or sell? Read more here...

Tags: Barrick
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Quanterix Stock
Analysis

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Vigil Neuroscience Stock
Healthcare

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Next Post
Redcare Pharmacy Stock

Redcare Pharmacy Shares Plunge Amidst Growth Paradox

Super Micro Computer Stock

Super Micro Computer Shares Continue Their Steep Decline

MercadoLibre Stock

MercadoLibre Shares Face Profitability Test Amid Rapid Expansion

Recommended

Biotechnology Stock Exchange

Analysts Bullish on Dynatrace with Price Targets on the Rise

2 years ago
The Trade Desk Stock

The Trade Desk Faces Mounting Pressure as Amazon Strikes Netflix Deal

5 months ago

Analyst Reaffirms Buy Rating on International Seaways with 66 Price Target

2 years ago
Biotechnology Stock Bull Market

KeyBanc Analyst Raises Price Target and Maintains Overweight Rating on Repligen NASDAQ RGEN

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Trending

Puma Biotechnology Stock
Earnings

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

by Jackson Burston
February 8, 2026
0

Investor attention is now firmly fixed on February 26, 2026, as Puma Biotechnology prepares to release its...

Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026
Design Therapeutics Stock

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

February 7, 2026
Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Puma Biotechnology Sets Date for Full-Year Financial Disclosure
  • Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test
  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com